Donor Login
Contact Us
JDRF
About
Investment Strategy
Portfolio
Our People
Venture Philanthropy
News
Donor Login
Get in touch
News and Press
Repertoire Immune Medicines Secures $189M Financing to Advance Pipeline Programs and Discovery Platform Directed at Cellular Immune Targets
April 13, 2021 |
CAMBRIDGE, MA
T1D Fund in the News
Venture Models Can Accelerate Cures but Aren’t for the Faint of Heart
April 09, 2021 |
HBS Kraft Precision Medicine Accelerator
Interview with portfolio company IM Therapeutics on HLA targeted immune therapy treatments
March 30, 2021
Taking gene therapy to the masses with innovations in diabetes, Alzheimer’s and more
March 30, 2021
eGenesis Announces $125 Million Series C Financing
March 02, 2021 |
CAMBRIDGE, MA
